NCT00731185View on ClinicalTrials.gov

Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)

PHASE3CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

September 1, 2003

Primary Completion Date

September 1, 2005

Study Completion Date

September 1, 2005

Conditions
Nasal Polyps
Interventions
DRUG

Mometasone Furoate Nasal Spray

MFNS 200 mcg (2 sprays of 50 mcg in each nostril) once daily in the morning for up to 24 weeks or until relapse

DRUG

Placebo

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00731185 - Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218) | Biotech Hunter | Biotech Hunter